GlassScriptPhysician profile
Nancy L Cote
NPI 1568401735
$2,892.97
in general payments reported to CMS, 2019-2025
20 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.51 · 2023: $185 · 2024: $1,548 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.48 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $896.77 | 2023-2025 | |
| Janssen Biotech, INC. | $360.03 | 2023-2025 | Tremfya |
| Amgen INC. | $242.98 | 2023-2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $209.65 | 2025 | |
| Arcutis Biotherapeutics, INC. | $164.99 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $153.36 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $133.76 | 2023-2025 | Dupixent |
| Incyte Corporation | $118.98 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $100.97 | 2024-2025 | |
| Genzyme Corporation | $96.66 | 2024 | |
| Pfizer INC. | $81.21 | 2023-2025 | |
| Galderma Laboratories, L.P. | $61.70 | 2024-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $57.72 | 2024 | Sotyktu |
| Ucb, INC. | $54.92 | 2024-2025 | Bimzelx |
| Leo Pharma INC. | $51.86 | 2024 | Adbry |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.92 | 2024 | Jublia |
| Kci USA, INC. | $32.64 | 2022 | |
| Merz North America, INC. | $18.87 | 2022 | |
| Lnhc, INC | $14.86 | 2025 | Zelsuvmi |
| Organon LLC | $8.12 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.